XML 18 R6.htm IDEA: XBRL DOCUMENT v3.3.1.900
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Operating activities:    
Net loss $ (54,701) $ (36,679)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Amortization and impairment of software development costs and licenses 83,056 89,768
Depreciation and amortization 21,462 15,123
Stock-based compensation 54,144 52,474
Deferred income taxes   641
Amortization of discount on Convertible Notes 17,454 16,389
Amortization of debt issuance costs 1,181 1,260
Gain on long-term investments, net   (17,476)
Amortization and impairment of intellectual property 160 320
Other, net 2,573 2,262
Changes in assets and liabilities:    
Restricted cash (34,411) 162,538
Accounts receivable (46,227) (382,566)
Inventory (374) 5,163
Software development costs and licenses (170,074) (155,454)
Prepaid expenses, other current and other non-current assets (6,514) (52,092)
Deferred revenue 184,955 456,623
Deferred cost of goods sold (54,418) (63,203)
Accounts payable, accrued expenses and other liabilities 190,557 (34,565)
Net cash provided by operating activities 188,823 60,526
Investing activities:    
Change in bank time deposits (189,564)  
Sales and maturities of available-for-sale securities 19,014  
Purchases of available-for-sale securities (25,768) (79,677)
Purchases of fixed assets (28,579) (36,579)
Purchase of long-term investments   (5,000)
Cash received from sale of long-term investment   21,976
Net cash used in investing activities (224,897) (99,280)
Financing activities:    
Excess tax benefit from stock-based compensation 1,509 10,352
Tax payment related to net share settlements on restricted stock awards (14,506)  
Repurchase of common stock (26,552)  
Net cash (used in) provided by financing activities (39,549) 10,352
Effects of foreign currency exchange rates on cash and cash equivalents (256) (9,546)
Net decrease in cash and cash equivalents (75,879) (37,948)
Cash and cash equivalents, beginning of year 911,120 935,400
Cash and cash equivalents, end of period $ 835,241 $ 897,452